The recent 10% Q over Q growth has been discouraging but within the next couple days I hope to see at least 20%+ growth. I think a quick trigger with confirmation would be great timing for sideline investors considering the discount we are seeing vs future potential. If there is a paradigm shift in what is considered the standard for cold chain shipping then CYRX is positioned very well as we have a practical monopoly with the 3 largest shippers committed to our product. CROs and pharma's dependence on successful trials could make CYRX's solution a no brainer regardless of the added cost. i am bullish and may throw some more $ at her if the next quarterly financials are promising
News 
Market Data 
Discover 
